
Photo: Bloomberg
Antibody Cocktail For Treating COVID-19 Launched At Rs 59,750/Dose
Drug company Roche India and Cipla have jointly launched 'Antibody Cocktail' of Casirivimab and Imdevimab, for treating COVID-19 patients above 12 years of age. A single dose pack (1200mg) of the cocktail has been priced at Rs 59,750 while the multiple dose pack, meant for two patients, will cost Rs 1,19,500. As per claims, the drug can reduce fatality by 70% and shortens symptoms' duration by four days.